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Summary  
Eighty-five percent of male STR/ort mice develop osteoarthritic lesions of the knee joint by 35 weeks of age. We have 
developed a non-radioactive in-situ hybridization method using digoxigenin-labeled oligonucleotide probes to study 
the expression of the cytokines interleukin (IL) 1~, I1-1~ and IL-6 and the growth factors insulin-like growth factor-1 
(IGF-1) and transforming growth factor ~ (TGF[~I) during the development ofosteoarthritis (OA) in this model. Age- 
and sex-matched CBA mice, which do not develop OA, showed no detectable xpression of any of the cytokines or 
growth factors tudied. In contrast, 20-week-old STR/ort mice with no OA lesions howed positive xpression [positive: 
(+)] for all the cytokines and growth factors tudied. At 35 weeks of age, STR/ort mice with varying grades of OA 
showed positive (+) or strong (+ +) signals for both cytokines and growth factors throughout the tibial articular 
cartilage. The strongest ignal was seen in areas where OA lesions were present. In areas of histologically-normal 
cartilage adjacent to the lesions, the signals were still positive but weaker. Fifty-week-old STR/ort mice with OA lesions 
showed asimilar pattern of expression to 35-week-old mice, Thirty-five or 50-week-old STR/ort mice with no OA lesions 
had much reduced expression compared with those with OA lesions. These mice may be indicative of those STR/ort 
mice which do not develop OA. The results seen in the STR/ort together with previous biochemical analyses are 
consistent with an up-regulation ofanabolic growth factors and catabolic ytokines in the prelesional stages of OA 
with anabolic effects predominating. At later stages of OA, the effects of catabolic factors appear to predominate and 
osteoarthritic lesions become vident. 
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Introduction 
OSTEOARTHRITIS (OA) is the most common 
arthropathy of synovial joints. However, the 
cellular and biochemical basis of OA is obscure. By 
the time human osteoarthritic joints become 
available for sampling, the disease has advanced to 
a stage where it is difficult to determine which 
changes are fundamental nd which are secondary 
to the disease process. Consequently, animal 
models must be used to study early changes in the 
disease and its progression. We have used the male 
STR/ort mouse which develops natural OA of the 
tibial articular cartilage for this. 
The STR/ort mouse was studied extensively by 
Walton [1, 2], who showed that most male mice 
have established joint arthropathy by the age of 6 
months. Histological lesions of OA develop first in 
the medial tibial plateau. We have found that 85% 
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of male STR/ort have overt histological lesions by 
35 weeks of age. The lateral plateau also developed 
OA but of a lesser severity and later onset. The 
lesions closely resemble those in OA of the knee in 
humans [3]. Studies of the proteoglycan content of 
murine tibial articular cartilage have shown an 
elevation in both the medial and lateral tibial 
plateau of male STR/ort mice at 16--19 weeks of age 
compared with that found in male CBA mice, 
which do not develop OA [4]. There is a marked 
decrease in proteoglycan content of the cartilage 
thereafter. We have found that histological OA 
lesions begin to develop in male STR/ort mice 
between 10 and 20 weeks of age. 
It has been shown that cartilage proteoglycan 
synthesis is stimulated by the growth factors 
insulin-like growth factor-1 (IGF-1) and transform- 
ing growth factor beta (TGF~I) [5], and is inhibited 
by the cytokines interleukin-l-alpha (IL-lu) and 
interleukin-l-beta (IL-I~) [5]. IL-1 has also been 
implicated in stimulating proteoglycan turnover, 
and it is thought hat some of its effects may be 
mediated through interleukin-6 (IL-6) [6]. The aims 
of this study were, therefore, to investigate 
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whether murine tibial articular chondrocytes 
express these growth factors and cytokines, and 
whether changes in the expression of these factors 
in the male STR/ort mouse occur before, during 
and after the development of OA lesions. 
Materials and Methods 
REMOVAL OF KNEE JOINTS, CHILLING AND 
SECTIONING 
For each age group of 20, 35 and 50 weeks, eight 
male STR/ort mice and six age- and sex-matched 
CBA strain control mice were killed by cervical 
dislocation, the skin removed from the legs and the 
knee joints dissected out with the associated 
muscle. The patella was marked with indelible ink 
to assist orientation for sectioning. The knee joints 
were dipped briefly in 5% aqueous solution of 
polyvinyl alcohol (GO4/140, Wacker Chemicals 
Ltd., Walton-on-Thames, Surrey, U.K.) and then 
chilled to -70°C in n-hexane, cooled by industrial 
methylated spirit and solid carbon dioxide [7]. 
They were stored dry at -70°C until sectioning. 
For sectioning, the knee joints were mounted on 
metal chucks with the patella uppermost. Section- 
ing was in an anterior to posterior direction. Serial 
unfixed and undecalcified sections of 10 ~m were 
cut through the whole knee joint using a Bright's 
bone-cutting cryostat fitted with automatic drive 
to ensure sections of constant thickness. The 
cabinet temperature was -30°C and the tungsten 
carbide tipped knife was cooled by CO2-ice packed 
around its haft. The sections were flash-dried on to 
glass slides that had been cleaned in acid-alcohol, 
baked at 200°C and subbed with 2% Tespa 
(3-aminopropylthiethoxysilane) i  acetone. The 
sections were stored dry at -20°C. 
IN -S ITU HYBRIDIZATION 
All glassware used was cleaned with 2% absolve 
(DuPont) and baked at 200°C. Solutions were 
prepared using 0.1% diethyl pyrocarbonate 
(DEPC) treated and autoclaved eionized istilled 
water (dH~O). Solutions were autoclaved again 
before use. This eliminates any RNase activity. 
PRETREATMENT OF SECTIONS 
Sections were removed from the freezer and 
allowed to reach room temperature. They were fixed 
in freshly prepared 4% paraformaldehyde in 
phosphate-buffered saline (PBS) for 20 min, washed 
twice for 5 rain in PBS and digested with proteinase 
K (100 ~g/ml in 50 mM Tris HC1 buffer, 5 mM EDTA, 
pH 8, for 10 min. These conditions were found to be 
optimal for subsequent oligonucleotide probe 
penetration into murine articular cartilage. The 
sections were washed in PBS, refixed in 4% 
paraformaldehyde in PBS and rinsed in dH~O. 
Sections were immersed in 0.25% acetic anhydride 
in 0.1M triethanolamine HC1, pH8 for 10rain, 
washed twice in PBS and allowed to air dry before 
hybridization. 
HYBRIDIZATION 
Probes for the growth factors, IGF-1 and TGF~I, 
and the cytokines, IL-I~, IL-I~ and IL-6 were used. 
The probes were cocktails of single strand 
antisense oligonucleotides for each growth factor 
and cytokine supplied by R and D Systems Ltd., 
Abingdon, U.K. Each cocktail contained equi- 
molar amounts of three to four different exon- 
specific oligonucleotide probes, polyA-mRNA was 
detected with an oligo dT probe (R and D Systems 
Ltd.). The probes were labelled with digoxigenin at 
both 5' and 3' ends. A digoxigenin-labeled oligo dT 
probe was used as a control. 
The probes were used at a concentration of 
2.5 ng/pl in 50% deionized formamide in hybridiz- 
ation buffer (Amersham International plc, U.K.). 
Hybridization solution was applied to each section 
which was then covered with a coverslip. The 
sections were hybridized overnight in a humid 
atmosphere at 42°C. Control sections were hy- 
bridized with hybridization buffer alone and after 
treatment with RNase. 
POST HYBRIDIZATION 
The sections were soaked in 5xSSC (standard 
saline citrate, pH 7), 10 mM DTT (dithiothreitol) at 
50°C to remove the coverslips, washed for 60 min at 
65°C in 50% formamide, 2xSSC, 20mm DTT, 
followed by 2 x SSC, then 0.1 x SSC for 15 rain each. 
PROBE DETECTION 
The sections were washed in Tris-buffered 
saline, pH 7.5 (TBS), incubated in heat-inactivated 
normal lamb's serum for 10 min and 5% blocking 
reagent (Amersham) in TBS for 60min. The 
sections were washed in PBS and incubated with 
an anti-digoxigenin gold-labeled antibody, diluted 
1:30 in PBS and bovine serum albumin ( lmg 
BSA/ml PBS), for 30 min at room temperature. The 
sections were rinsed in PBS and washed five times 
in distilled water. The gold-labeled antibody was 
then enhanced with the Amersham Inten SE TM M 
Silver Enhancement Kit for 30 min. The enhance- 
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ment was stopped by rinsing the sections twice in 
dH20. This time was found to be optimal for 
detecting hybridization. After air drying the 
sections were mounted in DPX mountant and 
probes visualized using epipolarization or dark- 
field microscopy. Hybridization signals were 
graded as nil (-), positive (+) or strongly positive 
(+ +) by two observers. 
The sections were graded for histological 
osteoarthritic change: grade 0=no change; 
1 = roughened articular surface and small fibrilla- 
tions; 2 = fibrillations down to zone 2 and some loss 
of the surface lamina; 3 = loss of surface lamina and 
fibrillations extending down to the calcified 
cartilage: 4=major fibrillations and cartilage 
erosion down to subchondral bone; 5=major 
fibrillations and erosion of up to 80% of the 
cartilage; 6 = greater than 80% loss of cartilage. As 
osteoarthritic lesions are more prevalent in the 
medial tibial cartilage the osteoarthritic grades 
listed in Tables I, II and III refer to lesions of the 
medial tibial cartilage. It should be noted that 
lesions of the lateral cartilage did not exceed 
grades 1 or 2 in this study. 
Results 
CBA male mice did not show histological lesions 
of OA in the tibial articular cartilages at any age. 
Expression ofIL-l~, IL-I~, IL-6 IGF-1 or TGF~I was 
FIG. 1. IGF-1 expression i murine tibial cartilage. IGF-1 mRNA was detected in the medial tibial articular cartilage 
(C) of CBA and STR/ort mice by in-situ hybridization, as described in the Methods section. The subchondral bone (B) 
is also shown. (a) 35-week CBA probed for IGF-1; (b) 35-week CBA probed for polyA-mRNA; (c) 20-week STR/ort probed 
for IGF-1 (+); (d) 20-week STR/ort probed for IGF-1 ( + + );(e) 20-week STR/ort, no probe; (f) 20-week STR/ort, pretreated 
with RNase and probed for IGF-1. Magnification, ×72. 
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FIG. 2. Cytokine expression n medial tibial cartilage of 20-week STR/ort mice. (a), probed for IL-lu; (b), probed for 
IGF-1. The cartilage (C) shows no steoarthritic lesions. Magnification, x102. 
not detected in the tibial articular cartilage of 
CBA mice [Fig. l(a)]. The CBA mice did, however, 
show hybridization with an oligo dT probe 
[Fig. l(b)] used at the same concentration asthose 
used to detect growth factors and cytokines. 
STR/ort male mice showed hybridization signals 
for growth factors and cytokines at all the ages 
studied [Fig. l(c),(d)]. No signal was seen when 
sections were incubated with hybridization buffer 
without a probe or when the sections were treated 
with RNase before hybridization [Fig. l(e),(f)]. 
Fig. 1 shows the expression of cartilages after 
hybridizing to detect IGF-1. Positive hybridization 
results with probes for TGF~I, IL-I~, IL-I~ and IL-6 
(see below) had the same appearance. 
20-WEEK-OLD STR/ORT MICE 
Six of eight STR/ort male mice of 20 weeks of age 
showed no histological lesions of osteoarthritis, 
whilst two had very mild osteoarthritic changes 
(grades 1 and 2). However, all six mice without 
lesions showed positive signals for the growth 
factors (Table I, Fig. 2). Four of these mice also 
expressed all the cytokines, whilst one showed no 
signal for IL-I~ or IL-I~ and another no signal for 
IL-6 (Table I). 
The signal for the growth factors and cytokines 
was seen throughout the depth of the cartilage and 
occurred in both the medial and lateral tibial 
plateau cartilages. The signal tended to be 
stronger in the more osteoarthritic prone medial 
plateau. Cytokines and growth factors are, 
therefore, expressed before the development of 
histological lesions of osteoarthritis. 
In the 20-week-old STR/ort mice with os- 
teoarthritic lesions, each mouse showed expression 
of a selection of growth factors and cytokines 
(Table I). The signal distribution was similar to that 
in 20-week-old mice with no osteoarthritic lesions. 
35-WEEK-OLD STR/ORT MICE  
Three of eight 35-week-old STR/ort mice had no 
osteoarthritic lesions. In these mice, the ex- 
pression of cytokines and growth factors was 
variable (Table II). Two mice expressed both IL-6 
(+) and IGF-1 (+) and the third expressed IL-I~ (+) 
and TGF~I ( + + ). The distribution of these signals 
was very similar to that seen in 20-week-old mice. 
The variable expression of cytokines and growth 
factors in these lesion free mice contrasts with the 
strong expression seen in 35-week-old mice which 
have osteoarthritic lesions. 
Five of eight 35-week-old STR/ort mice have 
osteoarthritic lesions varying in severity from 
Table I 
In-situ hybr id izat ion  s ignals  in media l  t ibial 
art icular  carti lage of  20-week-old STR-or t  mice 
OA grade ILq~ IL-I~ IL-6 IGF-1 TGF[~I 
0 + + + + + 
0 - - + + + 
0 + + - + ++ 
0 + + + + + 
0 + + + + + 
0 + + + + + 
I - - + + +  _ 
2 + + + _ + 
Table II 
In-situ hybr id izat ion  s ignals in media l  t ibial 
art icular carti lage of 35-week-old STR.or t  mice 
OA grade IL-luIL-I~ IL-6 IGF-1 TGF~I 
0 - - + + - 
0 + - - - ++ 
0 - - + + - 
2 + + ++ ++ + 
2 ++ ++ ++ ++ + 
5 ++ + ++ ++ - 
6 ++ ++ + ++ + 
6 + + - ++ + 
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FIG. 3. IGF-1 expression around osteoarthritic lesions in a 35-week STR/ort mouse. The medial tibial cartilage in (a) 
shows major fibrillation and tissue lesions (L) and hybridized strongly (+ +) with the IGF-1 probe. A serial section 
(b) ~ 100 ~tm from the osteoarthritic lesions shows normal cartilage and only low expression of IGF-1 (+). Magnification, 
x92. 
grade 2 to grade 6. All these mice showed marked 
expression of cytokines and growth factors 
[Table II, Fig. 3(a)]. IGF-1 expression was strong 
(+ +) in all five mice. TGF~I expression was 
generally positive (+). IL-lu, IL-I[3 and IL-6 
expression was either strong (+ + ) or positive (+), 
apart from in one mouse in which IU6 expression 
was not detected. Growth factor and cytokine 
expression was strongest in sections howing the 
greatest osteoarthritic damage. The osteoarthritic 
lesions in these mice are focal. Serial sections 
progressively further away from a lesion have 
histologically normal cartilage but still express 
cytokines and growth factors. The signal (+) in 
these sections [Fig. 3(b)] is always weaker than at 
the site" of the lesion (+ +). This shows the 
importance of sectioning serially through a joint 
when investigating osteoarthritic disease in STR/ 
ort mice. 
osteoarthritic lesions (Table II). The distribution 
of signal in these mice was similar to that seen in 
20- and 35-week-old mice. It is likely that these 
animals represent those STR/ort mice which never 
develop osteoarthritic lesions. 
In the 50-week-old STR/ort mice with osteo- 
arthritic lesions three of the four mice showed 
positive (+) or strong (+ +) signal for all of the 
cytokines and growth factors (Table III). As with 
the 35-week-old mice with osteoarthritic lesions, 
the hybridization signals were strongest in the 
areas of cartilage closest to the lesion. One 
50-week-old mouse with grade 5 osteoarthritic 
lesions showed no expression of any of the 
cytokines or growth factors. However, this mouse 
did show a positive signal for the oligo dT probe. 
This result suggests that the expression of 
cytokines and growth factors by the chondrocytes 
may decline markedly in late-stage disease in older 
animals. 
50-WEEK-OLD STR/ORT MICE  
An unusually large number of the 50-week-old 
STR/ort mice in this series (4/8) showed no 
osteoarthritic lesions (Table III). In these mice, the 
expression of cytokines and growth factors was 
variable, as in 35-week-old STR/ort mice with no 
Table III 
In-situ hybridization signals in medial tibial 
articular cartilage of 50-week-old STR-ort mice 
OA grade IL-lu IL-l[3 IL-6 IGF-1 TGFf31 
0 - + + + ++ 
0 . . . . .  
0 - - ++ - - 
0 - + - + - 
4 ++ ++ ++ ++ ++ 
4 ++ + + + + 
5 - + + + ++ 
5 . . . . .  
Discussion 
The in-situ hybridization method used in this 
study was the subject of considerable development. 
Initially, we used the technique described by 
Wilkinson [8, 9], applying it to decalcified wax- 
embedded sections. However, tissue processing led 
to the loss of Alcian blue stainable proteoglycans 
from the cartilage matrix, suggesting that other 
macromolecules, including mRNAs, may not be 
well-retained in the tissue. We, therefore, used 
undecalcified cryostat sections for these studies. 
The experimental conditions such as protease 
concentration, hybridization temperature and the 
stringency of washes were optimized to give 
maximum signal in the articular cartilage with 
minimal background. The same conditions are not 
necessarily optimal for other tissues in the section 
such as bone or joint capsule. The silver-enhanced, 
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gold-labeled, anti-digoxygenin antibody system 
used to detect hybridization of DIG-labeled 
oligonucleotide probes in the cartilage was 
adopted after xperimenting with several other 
systems. The system appears to be well-suited to 
detecting mRNAs in articular cartilage. 
Male STR/ort mice develop a natural OA of the 
tibial plateau. In this study, we have shown that 
the articular chondrocytes of the tibial plateau 
express mRNA for various growth factors and 
cytokines, The signal for these factors varies with 
age and disease severity. Under the same exper- 
imental conditions, tibial rticular chondrocytes 
in male CBA mice did not express ignals for the 
same growth factors and cytokines at the ages 
studied. These mice never develop OA in our 
experience. Because th re is in vitro evidence that 
growth factors and cytokines play a role in the 
homeostasis of articular cartilage by promoting 
both anabolic and catabolic effects [5, 10], it is 
possible that the CBA mice express mRNA for 
these factors but at a level below the detection 
limits of our in-situ hybridization procedure. 
Alternatively, the CBA chondrocytes may not 
express these factors whilst still being able to 
respond to those from exogenous sources. This has 
been shown for IGF-1 in cultured normal bovine 
chondrocytes [11]. 
Most of the 20-week-old STR/ort mice in the 
study had no histological OA lesions. Neverthe- 
less, signals for all the growth factors and 
cytokines were detected in both the medial and 
lateral tibial articular chondrocytes. Intensity was 
always stronger in the more osteoarthritic-prone 
medial plateau. Although the signal for IGF-1 
appeared to be slightly stronger than that for the 
other factors, quantitative interpretation of in-situ 
hybridization results in tissue sections is problem- 
atic. Assessment relies on observer interpretation. 
We minimized this problem by having these 
sections graded independently b two observers. It
has been shown in ii~ vitro experiments on 
chondrocytes that IL-1 stimulates prostaglandin 
production and induces increased expression of 
matrix metalloproteinases, which results in matrix 
degradation [5]. IL-1 also strongly inhibits proteo- 
glycan synthesis and suppresses the synthesis of 
type II collagen, characteristic of articular 
cartilage, and promotes the synthesis of type I 
collagen, characteristic of fibroblasts [12]. The 
growth factors IGF-I and TGF~ have the opposite 
effects to IL-1 by stimulating protein synthesis, as 
well as suppressing matrix degradation. In exper- 
iments on porcine explant cultures it was found 
that when IL-1 and IGF-1 were added simul- 
taneously, IGF4 prevented the increase in matrix 
degradation caused by IL-1 and that recovery from 
IL-1 proteoglycan synthesis inhibition could be 
greatly improved by addition of IGF-1 or TGFI~ [5]. 
TGFI3 inhibits matrix degradation by stimulating 
protease inhibitor production, blocking collagen- 
ase and metalloprotease release [13], and promot- 
ing cartilage repair by stimulating production of 
collagen, fibronectin, inhibitors of plasminogen 
activators, and tissue inhibitors of metallo- 
proteinases (TIMP) by cells in the joint [14, 15]. 
TGF~ is thought o inhibit IL-l~-mediated degra- 
dation of articular cartilage by decreasing IL-113 
receptor expression [16] and by increasing inter- 
leukin-1 receptor antagonist (IRAP) expression 
[17]. However, TGF~ can also induce IL-I~ 
production [18]. The other cytokine studied, IL-6, is 
less well understood. It has been suggested that the 
inhibition of proteoglycan synthesis in human 
cartilage by IL-I could be mediated by IL-6, and it 
has been shown that IL-1 induces the secretion of 
IL-6 by human chondrocytes [19]. However, IL-6 
does not appear to affect the proteoglycan 
synthesis or expression of matrix metallo- 
proteinases in bovine chondrocytes [20], but seems 
to stimulate the production of TIMP in a variety of 
connective tissue cells [21, 22]. IL-6 may protect 
cartilage from matrix degradation i duced by IL-1 
in this way. 
In a previous biochemical analysis, we found a 
much higher total concentration of proteoglycan 
in the articular cartilage of 16- to 19-week-old male 
STR/ort mice than in CBA mice [4]. Also mRNA 
levels for aggrecan were two- to threefold higher 
in STR/ort cartilage at this age [23]. By 24-26 
weeks the cartilage proteoglycan content was 
markedly reduced in the STR/ort mice. Thus. 
although both anabolic growth factors and 
catabolic cytokines are xpressed in 20-week-old 
STR/ort tibial cartilage, the overall picture indi- 
cates that anabolic effects predominate at a stage 
of the disease process when either no histological 
lesions are present or only very minimal lesions 
have developed. The prelesional state of the 
STR/ort articular cartilage appears to be similar to 
that found in the early stages of experimentally-in- 
duced osteoarthritis n the dog. Following section 
of the canine anterior cruciate ligament, and 
before histological lesions of OA occur, there is 
increased synthesis of proteoglycan i the tibial 
cartilage [24] due, at least in part, to increased 
expression of aggrecan by its chondrocytes. 
By 35 weeks of age there was a marked ifference 
in cytokine and growth factor expression between 
those mice which show histological lesions of OA 
and those which do not. In those with lesions, there 
was strong expression of both growth 
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factors and generally of IL-I~, IL-I~ and IL-6. 
Again these factors were expressed throughout the 
cartilage, but signal was strongest in the regions 
around lesions. Lesion formation may be initiated 
by the action of matrix metalloproteinases, which 
are induced by IL-1 [25]. Pelletier et al. [26] 
detected IL-1 and the metalloproteinase enzyme 
stromelysin in cartilage areas adjacent to OA 
lesions in human joints. Higher concentrations of
stromelysin were detected in fibrillated cartilage 
compared with cartilage distant from the lesion. 
Metalloproteinase activity would be expected to 
degrade proteoglycans and other matrix macro- 
molecules. The total proteoglycan content of the 
male STR/ort tibial cartilage is much reduced at 35 
weeks of age compared with 16 19 weeks [4], 
suggesting that synthesis cannot maintain the 
matrix. The decreased proteoglycan concentration 
in the matrix is not uniformly distributed, as 
detected by Alcian blue staining (Chambers, 
unpublished work). The first marked depletion of 
matrix proteoglycan usually occurs in the medial 
tibial cartilage adjacent to the insertion of the 
anterior cruciate ligament. This site is also usually 
the first to show overt histological lesions of 
osteoarthritis. Subsequently, other areas of matrix 
become depleted of proteoglycans. This occurs 
despite the strong expression of the anabolic 
growth factor, IGF-1, throughout the articular 
cartilage. Presumably, the balance of cytokine 
expression at this stage favours catabolism 
induced by strong expression of IL-1. Expression 
does not automatically equate with activity, 
although Middleton et al. [27] have demonstrated 
IGF-1 protein in regions of human osteoarthritic 
cartilage expressing IGF-1 mRNA. However, 
IGF-binding proteins may inhibit the activity of 
the growth factor. Dore et al. [28] showed that 
although human OA chondrocytes express IGF-1 
receptors, and have increased numbers of binding 
sites for the growth factor, they are nevertheless 
unresponsive to IGF-1 stimulation. It was shown 
that IGF-binding proteins are responsible for this 
lack of response. 
In contrast to 35-week-old mice with articular 
cartilage lesions, those showing no lesions showed 
little evidence of IL-1 expression, and generally 
low expression of growth factors. These animals 
are representative of those STR/ort mice which 
either develop histological lesions of OA at a late 
age, or which never show such lesions. The 
different pattern of expression of cytokines and 
growth factors in the lesion-free and lesion-bearing 
mice suggests that their upregulation in chondro- 
cytes plays an important role in the development 
of histopathological change in the cartilage. 
Overall about 85% of male STR/ort mice develop 
osteoarthritic lesions by 50 weeks of age. In this 
particular survey, only 50% of the mice showed 
evidence of histopathological lesions and these 
were severe (grade 4-5). Most of these mice had 
similar patterns of cytokine and growth factor 
expression to those found in 35-week-old animals 
with osteoarthritic lesions, although the hybridiz- 
ation signals tended to be weaker. One animal with 
grade 5 changes howed no expression of any other 
cytokines or growth factors, although its chondro- 
cytes had a positive signal when sections were 
hybridized with the oligo dT probe. Collectively, 
these results suggest that cytokine and growth-fac- 
tor expression is a feature of early and developing 
osteoarthritis, but that it declines and may become 
negligible in late stage disease. 
The results discussed are for the medial tibial 
articular chondrocytes. The lateral tibial chondro- 
cytes also expressed mRNAs for the growth factors 
and cytokines at levels slightly less than those seen 
in the medial cartilage but with similar distri- 
bution. Because OA lesions develop primarily in 
the medial tibial cartilage, it suggests that other 
factors are involved. One possibility is that 
different mechanical factors act on the two sides of 
the joint. 
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